Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Slide Insurance Holdings (SLDE) Liabilities and Shareholders Equity (2024 - 2026)

Slide Insurance Holdings has reported Liabilities and Shareholders Equity over the past 3 years, most recently at $2.9 billion for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $2.9 billion; the TTM value through Mar 2026 reached $11.3 billion, up 485.0%, while the annual FY2025 figure was $2.9 billion, 51.06% up from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 was $2.9 billion at Slide Insurance Holdings, down from $2.9 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $2.9 billion in Q4 2025 and troughed at $1.9 billion in Q4 2024.
  • A 3-year average of $2.6 billion and a median of $2.8 billion in 2025 define the central range for Liabilities and Shareholders Equity.
  • On a YoY basis, Liabilities and Shareholders Equity climbed as much as 51.06% in 2025 and fell as far as 51.06% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $1.9 billion in 2024, then surged by 51.06% to $2.9 billion in 2025, then decreased by 1.24% to $2.9 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for SLDE at $2.9 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.7 billion in Q3 2025.